摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-fluoro-4-oxo-4H-chromene-2-carboxylic acid {1-[3-fluoro-4-(2-oxo-ethoxy)-benzyl]-piperidin-4-yl}-amide | 865450-71-1

中文名称
——
中文别名
——
英文名称
7-fluoro-4-oxo-4H-chromene-2-carboxylic acid {1-[3-fluoro-4-(2-oxo-ethoxy)-benzyl]-piperidin-4-yl}-amide
英文别名
7-fluoro-N-[1-[[3-fluoro-4-(2-oxoethoxy)phenyl]methyl]piperidin-4-yl]-4-oxochromene-2-carboxamide
7-fluoro-4-oxo-4H-chromene-2-carboxylic acid {1-[3-fluoro-4-(2-oxo-ethoxy)-benzyl]-piperidin-4-yl}-amide化学式
CAS
865450-71-1
化学式
C24H22F2N2O5
mdl
——
分子量
456.446
InChiKey
AMWIJEBBPCNDIH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    33
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    84.9
  • 氢给体数:
    1
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-fluoro-4-oxo-4H-chromene-2-carboxylic acid {1-[3-fluoro-4-(2-oxo-ethoxy)-benzyl]-piperidin-4-yl}-amide乙氧基胺盐酸盐三乙胺 作用下, 以 乙醇 为溶剂, 反应 16.0h, 生成 N-[1-(4-{[(2E)-2-(ethoxyimino)ethyl]oxy}-3-fluorobenzyl)piperidin-4-yl]-7-fluoro-4-oxo-4H-chromene-2-carboxamide mono-trifluoroacetate
    参考文献:
    名称:
    Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
    摘要:
    本发明涉及式(I)的化合物,通过对抗黑素浓集激素(MCH)的作用,通过对抗黑素浓集激素受体,有助于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质稳态、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫、神经退行性疾病和精神障碍。
    公开号:
    US20050209274A1
  • 作为产物:
    参考文献:
    名称:
    Identification of diamino chromone-2-carboxamides as MCHr1 antagonists with minimal hERG channel activity
    摘要:
    A series of potent 2-carboxychromone-based melanin-concentrating hormone receptor I (MCHrl) antagonists were synthesized and evaluated for hERG (human Ether-a-go-go Related Gene) channel affinity and functional blockade. Basic dialkyl-amine-terminated analogs were found to weakly bind the hERG channel and provided marked improvement in a functional patch-clamp assay versus previously reported antagonists of the series. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.11.068
点击查看最新优质反应信息

文献信息

  • Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
    申请人:Lynch K. John
    公开号:US20050209274A1
    公开(公告)日:2005-09-22
    The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    本发明涉及式(I)的化合物,通过对抗黑素浓集激素(MCH)的作用,通过对抗黑素浓集激素受体,有助于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质稳态、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫、神经退行性疾病和精神障碍。
  • Identification of diamino chromone-2-carboxamides as MCHr1 antagonists with minimal hERG channel activity
    作者:Andrew S. Judd、Andrew J. Souers、Dariusz Wodka、Gang Zhao、Mathew M. Mulhern、Rajesh R. Iyengar、Ju Gao、John K. Lynch、Jennifer C. Freeman、H. Douglas Falls、Sevan Brodjian、Brian D. Dayton、Regina M. Reilly、Gary Gintant、James T. Limberis、Ann Mikhail、Sandra T. Leitza、Kathryn A. Houseman、Gilbert Diaz、Eugene N. Bush、Robin Shapiro、Victoria Knourek-Segel、Lisa E. Hernandez、Kennan C. Marsh、Hing L. Sham、Christine A. Collins、Philip R. Kym
    DOI:10.1016/j.bmcl.2006.11.068
    日期:2007.4
    A series of potent 2-carboxychromone-based melanin-concentrating hormone receptor I (MCHrl) antagonists were synthesized and evaluated for hERG (human Ether-a-go-go Related Gene) channel affinity and functional blockade. Basic dialkyl-amine-terminated analogs were found to weakly bind the hERG channel and provided marked improvement in a functional patch-clamp assay versus previously reported antagonists of the series. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多